Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01830881 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Oral Midazolam in First-trimester Surgical Abortions
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 124
- Enrollment target
NCT01830881 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 124 participants.
The verdict
NCT01830881, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 124 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the level of pain, anxiety and side effects that women experience with a surgical abortion and the effect that the anti-anxiety medication, midazolam, might have when used along with ibuprofen and a paracervical block (PCB) instead of the standard pain treatment of only ibuprofen and a PCB.
Interventions
- DRUG Ibuprofen
- DRUG Midazolam
- DRUG Lidocaine
- OTHER Placebo-Cherry syrup
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01830881
The ClinicalTrials.gov registry entry for NCT01830881 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ibuprofen is the first listed.
NCT01830881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01830881 about?
NCT01830881 is a clinical study titled "Evaluation of Oral Midazolam in First-trimester Surgical Abortions". The purpose of this study is to determine the level of pain, anxiety and side effects that women experience with a surgical abortion and the effect that the anti-anxiety medication, midazolam, might have when used along with ibuprofen and a paracervical block (PCB) instead of the standard pain treat...
What is the current status of trial NCT01830881?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 124 participants. The study started on 2013-04. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01830881?
The interventions under investigation include: Ibuprofen (DRUG), Midazolam (DRUG), Lidocaine (DRUG), Placebo-Cherry syrup (OTHER).
Who is sponsoring clinical trial NCT01830881?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.